Latest news with #shareconsolidation
Yahoo
6 days ago
- Business
- Yahoo
IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY
Issuer name: IDEX Biometrics ASA Ex. date: 4 July 2025 Type of corporate action: Share consolidation (reverse split) Previous ISIN: NO0013107490 New ISIN: NO0013536078 For further information contact:Anders Storbråten, CEO and CFOE-mail: anders@ About this noticeThis notice was published by Erling Svela, Vice president of finance, on 4 July 2025 at 08:00 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to Continuing Obligations at Oslo Børs Euronext and is published in accordance with section 5‑12 of the Norwegian Securities Trading Act.
Yahoo
03-07-2025
- Business
- Yahoo
Therma Bright Announces Share Consolidation
Toronto, Ontario--(Newsfile Corp. - July 3, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company") announces, further to its news release dated June 11, 2025, that effective Tuesday, July 8, 2025, the Company will consolidate the common shares in the capital of the Company (the "Shares") on the basis of one (1) post-consolidation Share for every eight (8) pre-consolidation Shares (the "Consolidation"). The new CUSIP number will be 883426207 and the new ISIN number will be CA8834262070 for the post-Consolidation Shares. The Company currently has 454,457,147 Shares issued and outstanding and there will be approximately 56,807,143 Shares, subject to rounding, issued and outstanding on a post-Consolidation basis. No fractional shares will be issued as a result of the Consolidation. Any fractional shares resulting from the Consolidation will be rounded down to the nearest whole Share. The Company's outstanding incentive stock options and warrants will be adjusted on the same basis (1:8) to reflect the Consolidation in accordance with their respective terms with proportionate adjustments to be made to the exercise prices. The Company's post-Consolidation Shares are expected to begin trading on the TSX Venture Exchange (the "TSXV") on or about July 8, 2025. Letters of transmittal with respect to the Consolidation will be mailed to all registered shareholders of the Company. All registered shareholders will be required to send their respective certificates representing the pre-Consolidation Shares along with a properly executed letter of transmittal to the Company's transfer agent, Olympia Trust Company (the "Transfer Agent"), in accordance with the instructions provided in the letter of transmittal. Additional copies of the letter of transmittal can be obtained through the Transfer agent at 1-587-774-2340 or by email to cssinquiries@ All shareholders who submit a duly completed letter of transmittal along with their respective pre-Consolidation Share certificate(s) to the Transfer Agent, will receive a post-Consolidation Share certificate or Direct Registration Advice representing the post-Consolidation Shares. About Therma Bright Inc. Therma Bright develops and partners on cutting-edge diagnostic and medical device technologies that address healthcare challenges. Therma Bright Inc. trades on the (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX). Visit: Therma Bright Fia, CEOrfia@ Follow us on X FORWARD-LOOKING STATEMENTS Certain statements in this news release constitute "forward-looking" statements. These statements relate to future events such as current and future development of Therma Bright's products and related technology as described in the news release. All such statements involve substantial known and unknown risks, uncertainties and other factors which may cause the actual results to vary from those expressed or implied by such forward-looking statements. Forward-looking statements involve significant risks and uncertainties, they should not be read as guarantees of future performance or results, and they will not necessarily be accurate indications of whether such results will be achieved. Actual results could differ materially from those anticipated due to several factors and risks. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions on the date of this news release, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any forward-looking statements whether because of new information, future events or otherwise, except as required under applicable securities regulations. Completion of the Consolidation remains subject to all necessary corporate and regulatory approvals. If the required approvals are not obtained, the Consolidation may not proceed as contemplated or at all. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release. To view the source version of this press release, please visit
Globe and Mail
03-07-2025
- Business
- Globe and Mail
Almonty Industries Announces 1-for-1.5 Share Consolidation in Anticipation of Potential Nasdaq Listing
Almonty Industries Inc. (' Almonty ' or the ' Company ') (TSX: AII) (ASX: AII) (OTCQX: ALMTF) (Frankfurt: ALI), a leading global producer of tungsten concentrate, is pleased to announce that it has filed articles of amendment to consolidate its issued and outstanding common shares (' Shares ') on the basis of one (1) post-consolidation Share for every one and a half (1.5) pre-consolidation Shares (the ' Consolidation '). The Consolidation was approved by shareholders of the Company (' Shareholders ') at the annual general and special meeting of Shareholders held on April 30, 2025. The Company is implementing the Consolidation for the reasons disclosed in the management information circular dated March 21, 2025 (the ' Circular '), including to facilitate a potential Nasdaq listing. The Company expects that the Shares will commence trading on a post-Consolidation basis at the start of trading on July 7, 2025 on the Toronto Stock Exchange (the " TSX '), subject to receipt of necessary exchange approvals. Following the Consolidation, the new CUSIP number for the Shares will be 020398707 and the new ISIN number will be CA0203987072. Trading on the Australian Securities Exchange in CHESS Depositary Interests (' CDIs ') representing the Shares will commence on a deferred settlement basis at the start of trading on July 8, 2025. Trading in post-Consolidation CDIs on a normal settlement basis will commence at the start of trading on July 17, 2025. The Company expects to have approximately 195,860,844 Shares (including CDIs) outstanding following the Consolidation, subject to rounding for any fractional Shares. No fractional Shares will be issued in connection with the Consolidation. In the event that a Shareholder would otherwise be entitled to receive a fractional Share upon the occurrence of the Consolidation, such fraction will be rounded down to the nearest whole number. All stock options, warrants and other rights to purchase or otherwise acquire Shares shall be adjusted to reflect the Consolidation in accordance with the terms and conditions governing such convertible securities. Almonty's transfer agent, Computershare Investor Services Inc. (' Computershare '), will mail a letter of transmittal to registered Shareholders of the Company providing instructions on how to exchange existing Share certificates or direct registration system (DRS) statements. A sample letter of transmittal is also available on the Company's profile on SEDAR+. Non-registered Shareholders who hold their Shares through a bank, broker or other nominee and who have questions regarding how the Consolidation will be processed should contact their nominee. Until surrendered to Computershare, each Share certificate or other evidence representing pre-Consolidation Shares will be deemed for all purposes to represent the number of post-Consolidation Shares to which the registered Shareholder is entitled as a result of the Consolidation. New holding statements will be dispatched to holders of CDIs on a post-Consolidation basis between July 10, 2025 and July, 16 2025. The Consolidation remains subject to the final approval of the TSX. Additional details regarding the Consolidation can be found in the Circular, which is available under the Company's profile on SEDAR+ at About Almonty Almonty is a diversified and experienced global producer of tungsten concentrate in conflict-free regions. The Company is currently mining, processing and shipping tungsten concentrate from its Panasqueira Mine in Portugal. Its Sangdong Mine in Gangwon Province, South Korea is currently under construction. The Sangdong Mine was historically one of the largest tungsten mines in the world and one of the few long-life, high-grade tungsten deposits outside of China. Almonty also has a significant molybdenum resource on a separate property adjacent to the tungsten orebody at the Sangdong Mine. Additional development projects include the Valtreixal Project in northwestern Spain and Los Santos Mine in western Spain. Further information about Almonty's activities may be found at and under Almonty's profile at and Legal Notice The release, publication, or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published, or distributed should inform themselves about and observe such restrictions. Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release. Cautionary Note Regarding Forward-Looking Information This news release contains 'forward-looking statements' and 'forward-looking information' within the meaning of applicable securities laws. All statements, other than statements of present or historical facts, are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and assumptions and accordingly, actual results could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are typically identified by words such as 'plan', 'development', 'growth', 'continued', 'intentions', 'expectations', 'emerging', 'evolving', 'strategy', 'opportunities', 'anticipated', 'trends', 'potential', 'outlook', 'ability', 'additional', 'on track', 'prospects', 'viability', 'estimated', 'reaches', 'enhancing', 'strengthen', 'target', 'believes', 'next steps' or variations of such words and phrases or statements that certain actions, events or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward-looking statements in this news release include, but are not limited to, statements concerning the Consolidation, the timing of trading of the Shares and CDIs on a post-Consolidation basis, the number of issued and outstanding Shares following completion of the Consolidation, the receipt of final approval for the Consolidation from the TSX, the delivery of letters of transmittal, the treatment of convertible securities in connection with the Consolidation, and a potential Nasdaq listing. Forward-looking statements are based upon certain assumptions and other important factors that, if untrue, could cause actual results to be materially different from future results expressed or implied by such statements. There can be no assurance that forward-looking statements will prove to be accurate. Key assumptions upon which the Company's forward-looking information is based include, without limitation, the timely delivery of letters of transmittal and the ability of the Company to obtain final approval of the Consolidation from the TSX and to meet Nasdaq listing requirements. Forward-looking statements are also subject to risks and uncertainties facing the Company's business, including, without limitation, the impact of general economic conditions, industry conditions, and dependence on regulatory approvals. Any of these risks could have a material adverse effect on the Company's business, financial condition, results of operations and growth prospects. Readers should consider reviewing the detailed risk discussion in the Company's most recent Annual Information Form and the Amended Management Discussion and Analysis for the three months ended March 31, 2025 filed on SEDAR+, for a fuller understanding of the risks and uncertainties that affect the Company's business and operations. Although Almonty has attempted to identify important factors that could cause actual results, level of activity, performance or achievements to differ materially from those contained in forward-looking statements, there may be other factors that cause results, level of activity, performance or achievements not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate and even if events or results described in the forward-looking statements are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, Almonty. Accordingly, readers should not place undue reliance on forward-looking statements and are cautioned that actual outcomes may vary. Investors are cautioned against attributing undue certainty to forward-looking statements. Almonty cautions that the foregoing list of material factors is not exhaustive. When relying on Almonty's forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Almonty has also assumed that material factors will not cause any forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.
Associated Press
03-07-2025
- Business
- Associated Press
Western Metallica Announces Share Consolidation
TORONTO--(BUSINESS WIRE)--Jul 2, 2025-- Western Metallica Resources Corp. (TSXV: WMS ) (' Western Metallica ' or the ' Company ') announces, subject to the approval of the TSX Venture Exchange (the 'TSXV'), that it will be undertaking a consolidation (the 'Consolidation') of its issued and outstanding Common Shares on the basis of ten (10) pre-Consolidation, existing, Common Shares for one (1) post-Consolidation Common Share. The Company expects that the Consolidation will enhance the marketability of the Common Shares as an investment and facilitate the completion of financings intended to fund future operations. The Company currently has 82,561,975 Common Shares issued and outstanding. Following the Consolidation, the Company expects to have 8,256,199 Common Shares issued and outstanding. No fractional Common Shares will be issued, fractions of less than one-half of a Common Share will be cancelled and fractions of at least one-half of a Common Share will be converted to a whole Common Share. Each shareholder's percentage ownership in the Company and proportional voting power remains unchanged after the Consolidation, except for minor changes and adjustments resulting from the treatment of any fractional Common Shares. Outstanding options, warrants and other rights to acquire Common Shares will likewise be adjusted according to the terms of the Consolidation. The Company anticipates its Common Shares will commence trading on a post-Consolidation basis on the Toronto Stock Venture Exchange (the " TSXV ") at market open on July 7, 2025. The new CUSIP number for the post-Consolidation Common Shares will be 95861P201 and the new ISIN number will be CA95861P2017. The name of the Company and trading symbol will remain the same after the Consolidation. The Consolidation has been approved by shareholders at the Company's Annual General and Special Meeting held on June 9 th, 2025 (refer to news release dated June 9 th, 2025) as well as its Board of Directors. About Western Metallica Resources Corp. Western Metallica is an Ontario registered company with its head office in Toronto, Ontario, trading on the TSX Venture Exchange under symbol WMS. Western Metallica is in the business of mineral resource exploration and development with interests in various projects including its 100% owned Nueva Celti Copper Property in the Ossa Morena belt in Andalusia, Spain, and three other gold projects located in the 'Navelgas Gold Belt' in Asturias, Spain (Penedela, Valledor and Sierra Alta). Further information of the Company can be found at: Cautionary Notes The TSXV has neither approved nor disapproved the contents of this press release. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press source version on CONTACT: Western Metallica Resources Corp. Gregory Duras Chief Executive Officer +1 416 576-3136 Email:[email protected] KEYWORD: NORTH AMERICA CANADA INDUSTRY KEYWORD: MINING/MINERALS NATURAL RESOURCES SOURCE: Western Metallica Resources Corp. Copyright Business Wire 2025. PUB: 07/02/2025 07:00 PM/DISC: 07/02/2025 07:00 PM
Yahoo
23-06-2025
- Business
- Yahoo
IDEX Biometrics ASA: New date for the share consolidation and ISIN change
Reference is made to the stock exchange notices from IDEX Biometrics ASA (the "Company") on 11 April and 6 June 2025 regarding the share consolidation and change of ISIN as resolved by the 11 April 2025 Extraordinary General Meeting in the Company (the "EGM"). Certain equity issues in IDEX, as previously announced, remain ongoing, and the effective date of the share consolidation will therefore be 4 July 2025, allowing completion of such equity issues prior to the effectiveness of the share consolidation. For further information, please contact: Kristian Flaten, CFO, Tel: +47 95092322 E-mail: ir@ About IDEX Biometrics: IDEX Biometrics ASA (IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit About this notice: This notice was issued by Kristian Flaten, CFO, on 18 June 2025 at 17:20 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to section 5-8 of the Norwegian Securities Trading Act (STA) and released in accordance with section 5-12 of the in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
